Efficacy and safety of dual intravenous artesunate plus quinine compared to intravenous artesunate for cerebral malaria in a triple blinded parallel multisite randomized controlled trial in Nigerian children: DUAL PAQ TRIAL Protocol

Evidence exists as to the criticality of the first 24  h in the management of cerebral malaria. The morbidity and the mortality rate (35%) with the current intravenous monotherapy for the initial treatment of c...

Source: Trials - October 20, 2021 Category: General Medicine Authors: Michael Abel Alao, Adebola Emmanuel Orimadegun, Olayinka Rasheed Ibrahim, Abayomi O. Oyenuga, Adanze Onyenonachi Asinobi, Daniel Adedosu Gbadero, Ifeoma Joy Okoye and Emmanuel Okechukwu Nna Tags: Study protocol Source Type: research